Live
PharmaVoiceInside the hiring process for biotech CEOsFierceBiotechApogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3Endpoints NewsSignos raises $20M as it eyes health plan, pharma relationshipsLabiotechAre we ready for the next wave of proximity degraders?PharmaVoiceIn Alzheimer’s, Bristol Myers sees big promise beyond amyloidFierceBiotechDexcom warns of stolen glucose monitors being sold by unauthorized dealersCellTPPP/p25 amyloid seeding activity as a specific biomarker for multiple system atrophyCellUncovering spatially resolved functional genomics with CRISPR screen sequencingEndpoints NewsWaypoint Bio raises $20M to run three CAR-T trials in ChinaFierceBiotechFDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm voteFierceBiotechKardigan itching for IPO to fund late-stage cardiovascular pipelineClinical OMICsHeart Health Impacted COVID-19 Deaths
Thermo Fisher Apr 12, 2026

Is Thermo Fisher Scientific (TMO) Pricing Look Stretched After Recent Share Price Rebound - simplywall.st

Is Thermo Fisher Scientific (TMO) Pricing Look Stretched After Recent Share Price Rebound - simplywall.st

Body unavailable. Use the original source.